ADIPOQ and coronary artery disorder: Mazzali et al. showed myocardial steatosis in subjects with coronary artery disease (CAD), describing a significant increase in lipid droplets (LDs) and metabolically active adipocytes interspersed among cardiomyocytes, which were positively associated with changes in BMI and circulating leptin and negatively with adiponectin (1).